ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,264,000 | -37.8% | 1,280,030 | -24.6% | 0.00% | 0.0% |
| Q3 2016 | $5,248,000 | +4.7% | 1,698,464 | +8.8% | 0.00% | 0.0% |
| Q2 2016 | $5,012,000 | +7.1% | 1,561,432 | +3.5% | 0.00% | 0.0% |
| Q1 2016 | $4,678,000 | -19.9% | 1,508,951 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $5,842,000 | -18.4% | 1,456,900 | -6.8% | 0.00% | -50.0% |
| Q3 2015 | $7,161,000 | -8.5% | 1,563,565 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $7,830,000 | -20.3% | 1,508,609 | -3.9% | 0.00% | 0.0% |
| Q1 2015 | $9,827,000 | +0.6% | 1,569,768 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $9,764,000 | +14.3% | 1,552,244 | +10.5% | 0.00% | 0.0% |
| Q3 2014 | $8,544,000 | -7.3% | 1,405,273 | +0.4% | 0.00% | -33.3% |
| Q2 2014 | $9,220,000 | -70.2% | 1,399,074 | +7.7% | 0.00% | -66.7% |
| Q1 2014 | $30,919,000 | +132.8% | 1,298,568 | +4.4% | 0.01% | +125.0% |
| Q4 2013 | $13,280,000 | -20.8% | 1,243,470 | -1.2% | 0.00% | -33.3% |
| Q3 2013 | $16,777,000 | +16.8% | 1,258,559 | +15.0% | 0.01% | +20.0% |
| Q2 2013 | $14,368,000 | – | 1,094,257 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 32,639 | $83,000 | 0.09% |
| Anson Funds Management LP | 108,426 | $276,000 | 0.09% |
| Leisure Capital Management | 30,038 | $77,000 | 0.07% |
| HIGHLAND CAPITAL MANAGEMENT LP | 461,561 | $1,177,000 | 0.06% |
| Teza Capital Management LLC | 14,542 | $37,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 821,543 | $2,095,000 | 0.04% |
| Cribstone Capital Management, LLC | 28,141 | $63,000 | 0.04% |
| RMB Capital Management, LLC | 243,385 | $621,000 | 0.03% |
| Acrospire Investment Management LLC | 26,061 | $66,000 | 0.03% |
| TWO SIGMA SECURITIES, LLC | 26,758 | $68,000 | 0.02% |